
4D Molecular Therapeutics, Inc. (FDMT) presented at the Morgan Stanley 24th Annual Global Healthcare Conference on September 14, 2026.
The presentation was given by company participants, including David Kirn, Co-Founder, President, CEO & Director, and Christopher Simms, Chief Commercial & Business Officer.
Key Takeaways
Center
Not enough sources yet on this side — a blindspot summary will appear once outlets cover the story.
Not enough sources yet on this side — a blindspot summary will appear once outlets cover the story.
Get every side of the week's biggest story in your inbox.
The presentation may have provided insight into 4D Molecular Therapeutics, Inc. (FDMT)'s current and future plans
No attributed perspective yet — we only show quotes grounded in analysis.
Evaluated across 1 reporting source (0% Left · 100% Center · 0% Right)
Historical editorial baseline for Seeking Alpha (US)
Multi-factor accuracy index for Seeking Alpha (US) and related desks based on verifiable sourcing and editorial standards.
Factuality: High 100%
Ownership: Seeking Alpha (US) (Corporate)
Public conversation related to this story
Loading comments…